Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery
The ocular delivery of drugs has always presented a pharmaceutical challenge. Various ocular barriers, such as reflex blinking, tear turnover, epithelial tight junctions, metabolism in ocular tissues, efflux pumps, nasolacrimal drainage, and other blood ocular barriers, restrict corneal permeation t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Journal of Bio-X Research |
| Online Access: | https://spj.science.org/doi/10.34133/jbioxresearch.0044 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850038201679347712 |
|---|---|
| author | Sandip Karmakar Sreejan Manna Tamal Jana Sougata Jana Gouranga Nandi |
| author_facet | Sandip Karmakar Sreejan Manna Tamal Jana Sougata Jana Gouranga Nandi |
| author_sort | Sandip Karmakar |
| collection | DOAJ |
| description | The ocular delivery of drugs has always presented a pharmaceutical challenge. Various ocular barriers, such as reflex blinking, tear turnover, epithelial tight junctions, metabolism in ocular tissues, efflux pumps, nasolacrimal drainage, and other blood ocular barriers, restrict corneal permeation to ocular therapeutic moieties. This has limited the ocular bioavailability for many drugs. The short residence time of the drug on the ocular surface area also limits bioavailability. The small size and attractive surface properties of liposomal formulations offer advantages in ocular drug permeation. Accordingly, liposome-based preparations have attracted increasing attention from pharmaceutical researchers for delivering drugs on the ocular surface. Recent research has supported the potential of liposomal carriers for the successful delivery of various drugs, including antiglaucoma, anti-inflammatory, anti-infection, and anti-hypertensive drugs. The various ocular barriers are discussed here in detail, and the synthesis regimes of several liposomal drug carriers are described along with their applications in delivering different therapeutic agents to the ocular region. This review concisely describes the current status and future prospects of liposomal drug delivery systems for ocular drug delivery. |
| format | Article |
| id | doaj-art-1bdae8e3a24f4b56920dc32543969ef8 |
| institution | DOAJ |
| issn | 2577-3585 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | American Association for the Advancement of Science (AAAS) |
| record_format | Article |
| series | Journal of Bio-X Research |
| spelling | doaj-art-1bdae8e3a24f4b56920dc32543969ef82025-08-20T02:56:39ZengAmerican Association for the Advancement of Science (AAAS)Journal of Bio-X Research2577-35852025-01-01810.34133/jbioxresearch.0044Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug DeliverySandip Karmakar0Sreejan Manna1Tamal Jana2Sougata Jana3Gouranga Nandi4Department of Pharmacy, Sanaka Educational Trust’s Group of Institutions, Durgapur, West Bengal 713212, India.Department of Pharmaceutical Technology, Brainware University, Barasat, Kolkata, West Bengal 700125, India.Department of Pharmaceutical Technology, Brainware University, Barasat, Kolkata, West Bengal 700125, India.Department of Health and Family Welfare, Directorate of Health Services, Kolkata, West Bengal 700091, India.Department of Pharmaceutical Technology, University of North Bengal, Darjeeling, West Bengal 734013, India.The ocular delivery of drugs has always presented a pharmaceutical challenge. Various ocular barriers, such as reflex blinking, tear turnover, epithelial tight junctions, metabolism in ocular tissues, efflux pumps, nasolacrimal drainage, and other blood ocular barriers, restrict corneal permeation to ocular therapeutic moieties. This has limited the ocular bioavailability for many drugs. The short residence time of the drug on the ocular surface area also limits bioavailability. The small size and attractive surface properties of liposomal formulations offer advantages in ocular drug permeation. Accordingly, liposome-based preparations have attracted increasing attention from pharmaceutical researchers for delivering drugs on the ocular surface. Recent research has supported the potential of liposomal carriers for the successful delivery of various drugs, including antiglaucoma, anti-inflammatory, anti-infection, and anti-hypertensive drugs. The various ocular barriers are discussed here in detail, and the synthesis regimes of several liposomal drug carriers are described along with their applications in delivering different therapeutic agents to the ocular region. This review concisely describes the current status and future prospects of liposomal drug delivery systems for ocular drug delivery.https://spj.science.org/doi/10.34133/jbioxresearch.0044 |
| spellingShingle | Sandip Karmakar Sreejan Manna Tamal Jana Sougata Jana Gouranga Nandi Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery Journal of Bio-X Research |
| title | Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery |
| title_full | Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery |
| title_fullStr | Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery |
| title_full_unstemmed | Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery |
| title_short | Unraveling the Therapeutic Enigma of Liposomes in Ocular Drug Delivery |
| title_sort | unraveling the therapeutic enigma of liposomes in ocular drug delivery |
| url | https://spj.science.org/doi/10.34133/jbioxresearch.0044 |
| work_keys_str_mv | AT sandipkarmakar unravelingthetherapeuticenigmaofliposomesinoculardrugdelivery AT sreejanmanna unravelingthetherapeuticenigmaofliposomesinoculardrugdelivery AT tamaljana unravelingthetherapeuticenigmaofliposomesinoculardrugdelivery AT sougatajana unravelingthetherapeuticenigmaofliposomesinoculardrugdelivery AT gouranganandi unravelingthetherapeuticenigmaofliposomesinoculardrugdelivery |